The characteristics of immune system changes in children who ingested melamine-contaminated powdered formula in China

Wenjie Zhou1, Yongmei Jiang, Hua Shi

  • 1West China Second University Hospital, Sichuan University, Chengdu, PR China.

Insights

Melamine poisoning in children can cause kidney stones and leukocyturia (white blood cells in urine) without typical urinary tract infection symptoms. Immune changes, including decreased CD3(+) and CD4(+) cells, were observed in affected children.

Area of Science:

  • Pediatric Nephrology
  • Toxicology
  • Immunology

Background:

  • Melamine poisoning from contaminated food poses a significant health risk to children.
  • The exact mechanism linking melamine to kidney stones and renal complications remains unclear.
  • Leukocyturia observed in affected children suggests potential immune system alterations.

Purpose of the Study:

  • To investigate the immune status of children who ingested melamine-contaminated formula.
  • To explore the relationship between melamine exposure, kidney stone formation, and immune response.
  • To understand the implications of leukocyturia in non-urinary tract infectious renal disease.

Main Methods:

  • Follow-up study of 170 children with documented melamine ingestion.
  • Blood and urine tests to assess immune markers (immunoglobulin M, CD3(+), CD4(+)).
  • Renal ultrasonography to detect kidney stones and complications.

Main Results:

  • Children with melamine-induced kidney stones showed a heightened immunoglobulin M response.
  • Decreased levels of CD3(+) and CD4(+) T-lymphocytes were noted in children with stones compared to those without.
  • No significant differences in complete blood counts were found between groups.

Conclusions:

  • Leukocyturia in children exposed to melamine is associated with non-urinary tract infectious renal diseases.
  • Children with melamine-related kidney issues may have altered immune profiles, increasing susceptibility to infections.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...